Elanco Animal Health logo

Elanco Animal Health

ELAN | NYSE
Chart Builder DCF Calculator
$22.43
+$0.01 (+0.04%)
At close: Sep 21, 2026, 3:59 PM ET
$22.99
+$0.56 (+2.50%)
Pre-market: Sep 22, 2026, 4:00 AM ET

Company Profile

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.

Key Executives

Name Position
Jeffrey N. Simmons President, Chief Executive Officer & Director
Robert VanHimbergen Executive Vice President & Chief Financial Officer
David S. Kinard Executive Vice President of Human Resources, Corporate Communications & Administration
Ellen de Brabander Executive Vice President of Research, Development & Regulatory Affairs
James Meer Senior Vice President & Chief Accounting Officer
Larbi Van Lier Senior Vice President of Asia
Ramiro Martin Cabral Executive Vice President & President of Elanco International
Shiv O'Neill Executive Vice President, General Counsel & Corporate Secretary
Tiffany Ann Kanaga Vice President of Investor Relations & ESG
Timothy J. Bettington Executive Vice President of Center of Strategic Growth

Latest SEC Filings

Date Type Title
Aug 25, 2026 4 Filing
Aug 25, 2026 4 Filing
Aug 25, 2026 4 Filing
Aug 21, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 13, 2026 4 Filing
Aug 10, 2026 4 Filing
Aug 10, 2026 4 Filing
Aug 10, 2026 4 Filing
Aug 10, 2026 4 Filing
View All SEC Filings
Elanco Animal Health
Elanco Animal Health logo
Country United States
IPO Date Sep 19, 2018
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 9,650
CEO Jeffrey N. Simmons

Contact Details

450 Elanco Circle Indianapolis, Indiana 46221 United States

Stock Details

Ticker Symbol ELAN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001739104
CUSIP Number 28414H103
ISIN Number US28414H1032
SIC Code 2834

© 2026 bestshares.com. All rights reserved.